Search Within

Konrad Hermann Stopsack

Formats
  1. Journal Article (39)
  2. Meeting Abstract (23)
  3. Editorial (4)
  4. Research Letter (3)
  5. Correspondence (1)
Groups
  1. Sloan Kettering Institute Postdocs (70)
  2. Department of Medicine (49)
  3. Genitourinary Oncology Service (49)
  4. Solid Tumor Oncology Division (49)
  5. GSK Faculty (16)
  6. Human Oncology and Pathogenesis Program (16)

More Groups

People
  1. Philip Kantoff (44)
  2. Subhiksha Nandakumar (15)
  3. Wassim Abida (15)
  4. Michael Morris (14)
  5. Goutam Chakraborty (13)
  6. Howard Scher (13)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (11)
  5. 2021 (15)
  6. 2020 (19)

More Years

Publications
  1. Cancer Research (11)
  2. Clinical Cancer Research (11)
  3. Journal of Clinical Oncology (11)
  4. European Urology (8)
  5. Cancer Epidemiology Biomarkers and Prevention (4)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Association for Cancer Research (31)
  2. American Society of Clinical Oncology (12)
  3. Elsevier Science, Inc. (9)
  4. Oxford University Press (5)
  5. Nature Publishing Group (3)
  6. John Wiley & Sons (2)

More Publishers

Results (70)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors
    Journal Article

    Chakraborty, G.; Khan Patail, N.; Hirani, R.; Nandakumar, S.; Mazzu, Y. Z.; Yoshikawa, Y.; Atiq, M.; Jehane, L. E.; Stopsack, K. H.; Lee, G. S. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib
    Research Letter

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save
  • Statins and prostate cancer: Bias, precision medicine, or population health?
    Editorial

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save
  • Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's letter to the editor re: Konrad H. Stopsack. Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
    Correspondence

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save
  • RNA eding of AZIN1 increases cellular aggressiveness in prostate cancer
    Meeting Abstract

    Ghalali, A.; Stopsack, K. H.; Rice, J. M.; Wang, L.; Wu, S.; Wu, C. L.; Zetter, B.; Rogers, M. S.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Multiplex immunofluorescence in formalin-fixed paraffin-embedded tumor tissue to identify single-cell-level PI3K pathway activation
    Journal Article

    Stopsack, K. H.; Huang, Y.; Tyekucheva, S.; Gerke, T. A.; Bango, C.; Elfandy, H.; Bowden, M.; Penney, K. L.; Roberts, T. M.; Parmigiani, G.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Single-cell multiplex immunofluorescence of formalin-fixed, paraffin-embedded prostate cancer tissue identifies PI3K pathway activation in two prospective cohort studies
    Meeting Abstract

    Stopsack, K. H.; Huang, Y.; Tyekucheva, S.; Gerke, T. A.; Bango, C.; Elfandy, H.; Gao, X.; Cai, Z.; Roberts, T. M.; Kantoff, P. W.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save